Ocugen, Inc.
OCGN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001372299
In the last 90 days, Ocugen, Inc. insiders filed 0 open-market purchases and 1 sale; 147 institutions reported holding it in 13F filings for Q2 2026, worth $222.1M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Ocugen, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 81 | 1 | 101 | +21 |
| Shares | 33.0M | 13.1K | 67.4M | +34.4M (+104.5%) |
| Value | $54.0M | $21.5K | $104.4M | +$50.4M (+93.5%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (44)
Institutions that held Ocugen, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (23)
Institutions that held Ocugen, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Millennium Management LLC | 1,925,755 | $3.16M |
| HRT Financial LP | 806,500 | $1.32M |
| Point72 Asia (Singapore) Pte. Ltd. | 366,940 | $601.8K |
| Squarepoint Ops LLC | 143,393 | $235.2K |
| Y-Intercept (Hong Kong) Ltd | 128,825 | $211.3K |
| Balyasny Asset Management LLC | 110,836 | $181.8K |
| TD Private Client Wealth LLC | 98,390 | $161.4K |
| Brevan Howard Capital Management LP | 69,268 | $113.6K |
| Omers Administration Corp | 67,400 | $110.5K |
| CTC Alternative Strategies, Ltd. | 62,800 | $103.0K |
| State Board of Administration of Florida Retirement System | 80,676 | $68.8K |
| Headlands Technologies LLC | 40,198 | $65.9K |
| Catalyst Funds Management Pty Ltd | 33,960 | $55.7K |
| Verition Fund Management LLC | 30,000 | $49.2K |
| DRW Securities, LLC | 24,200 | $39.7K |
| Wolverine Trading, LLC | 23,528 | $38.6K |
| Lanham O'Dell & Company, Inc. | 23,050 | $37.8K |
| Raymond James & Associates | 18,100 | $29.7K |
| Symmetry Investments LP | 15,000 | $24.6K |
| Tudor Investment Corp Et Al | 13,962 | $22.9K |
| Citadel Advisors LLC | 336 | $551 |
| Vima LLC | 365 | $311 |
| Macquarie Group Ltd | 5,883 | $10 |
Not filed for Q2 2024 yet (1)
Institutions that held Ocugen, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Retirement Group, LLC | 13,110 | $21.5K |